The Hub of Australian Finance News
OncoSil Medical Ltd (ASX:OSL) achieves significant clinical and financial milestones, expanding its global presence and enhancing its financial position in H1 2025.
Besra Gold Inc (ASX:BEZ) addresses unauthorised statements from Quantum Metals, clarifying gold resource figures and operational integrity.
Archer Materials Limited (ASX:AXE) improves Biochip’s potassium detection accuracy, advances to human blood testing, and plans regulatory engagements.
Reach Resources Limited (ASX:RR1) confirms initial assay results from Murchison South have a material impact on its securities, ensuring ASX listing compliance.
4DMedical (ASX:4DX) secures Canadian approval for CT LVAS™, expanding its respiratory imaging portfolio and market reach.
Great Northern Minerals Limited (ASX:GNM) explains the recent increase in trading activity due to strategic agreements and enhanced cash position.
Noumi Limited (ASX:NOU) reports revenue slightly up and EBITDA growth in its half-year financial results, despite an increased net loss.
Neuren Pharmaceuticals (ASX:NEU) receives FDA Rare Pediatric Disease Designation for NNZ-2591 in multiple syndromes, potentially qualifying for a priority review voucher.
Atlas Arteria (ASX:ALX) announces TRIP II has filed a federal complaint alleging constitutional violations related to the Dulles Greenway.
EDU Holdings Limited (ASX:EDU) reports a 151% increase in Trimester 1, 2025 enrolments, highlighting strong growth in its higher education business.
